PR

PROTALEX INC

  • CIK: 0001099215
  • EIN: 91-2003490
  • Business address: 131 COLUMBIA TURNPIKE, SUITE 1, FLORHAM PARK, New Jersey, 07932

Information

  • Mailing address
    131 COLUMBIA TURNPIKE, SUITE 1, FLORHAM PARK, Delaware, 07932
  • Phone
    215-862-9720
  • State location
    New Jersey
  • State of incorporation
    Delaware
  • Fiscal year end
    May 31
  • SIC
    8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • Filings
    N/A

About PROTALEX INC

PROTALEX INC (CIK: 0001099215) is an American company incorporated in the state of New Jersey. Head office is located at 131 COLUMBIA TURNPIKE, SUITE 1, FLORHAM PARK, New Jersey, 07932. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. PROTALEX INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
ELSER MARCO M 0001321913 Feb-04-2014 director
DOHERTY JOHN E 0001299552 Nov-27-2009 director
KLING ARNOLD P 0001276711 Nov-11-2009 director, 10 percent owner
WARSHAW KIRK M 0001276802 Nov-11-2009 officer: Chief Financial Officer
NIOBE VENTURES, LLC 0001476705 Nov-11-2009 10 percent owner
VSPRING SBIC LP 0001264704 Sep-08-2008 10 percent owner
TOMBROS PETER G 0001007933 Nov-08-2005 director
HOLSTROM CARLETON A 0001217515 Oct-25-2005 director
Sloan Victor S 0001337060 Aug-23-2005 officer: Senior VP and CMO
BAUER EUGENE A 0001210524 Feb-15-2005 director
Rose Marc L 0001309366 Nov-15-2004 officer: VP of Finance, CFO & Treasurer
Alila Hector W 0001312210 Mar-01-2004 officer: Senior VP of Drug Development
PATEL DINESH C 0000942991 Oct-28-2003 director
RAAB G KIRK 0001210530 Jul-08-2003 director
KANE STEVEN H 0001299861 Dec-16-2002 director, officer: President & CEO
STAGNARO THOMAS PETER 0001299856 Jul-08-2002 director
DOUGHERTY FRANK M 0001299556 Oct-16-2001 director

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PROTALEX INC

Filings Format Description Filed/Effective File/Film Number
REVOKED Document Acc-no: 9999999997-21-003666 (34 Act) Size: 286 KB Jun-28-2021

000-28385

211051084
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001144204-19-001579 (34 Act) Size: 25 KB		 Jan-14-2019

000-28385

19525131
8-K Document

Current report filing

Acc-no: 0001144204-18-062617 (34 Act) Size: 25 KB		 Nov-30-2018

000-28385

181211523
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-18-053662 (34 Act) Size: 1393 KB		 Oct-12-2018

000-28385

181120601
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0001144204-18-049024 (34 Act) Size: 5644 KB		 Sep-11-2018

000-28385

181064965
NT 10-K Document

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT

Acc-no: 0001144204-18-047097 (34 Act) Size: 23 KB		 Aug-29-2018

000-28385

181044408
RW Document

Registration Withdrawal Request

Acc-no: 0001144204-18-047089 (NE Act) Size: 6 KB		 Aug-29-2018

333-206008

181044354
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-18-020376 (34 Act) Size: 1567 KB		 Apr-13-2018

000-28385

18753114
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-014907 ( Act) Size: 13 KB		 Mar-15-2018

D Document Acc-no: 0001276711-18-000003 (33 Act) Size: 7 KB Mar-09-2018

021-307379

18680118
8-K Document

Current report filing

Acc-no: 0001144204-18-013055 (34 Act) Size: 311 KB		 Mar-06-2018

000-28385

18669900
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001144204-18-013051 (34 Act) Size: 49 KB		 Mar-06-2018

005-60195

18669887
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-012530 ( Act) Size: 12 KB		 Mar-02-2018

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-012529 ( Act) Size: 10 KB		 Mar-02-2018

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-007136 ( Act) Size: 9 KB		 Feb-12-2018

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-007134 ( Act) Size: 11 KB		 Feb-12-2018

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001144204-18-007132 ( Act) Size: 8 KB		 Feb-12-2018

10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-18-001695 (34 Act) Size: 1367 KB		 Jan-10-2018

000-28385

18521594
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-17-052043 (34 Act) Size: 1265 KB		 Oct-11-2017

000-28385

171132779
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0001144204-17-044755 (34 Act) Size: 4005 KB		 Aug-23-2017

000-28385

171047205

Recent 20 filings. View all PROTALEX INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • PROTALEX INC overview
  • PROTALEX INC job
  • PROTALEX INC stock
  • PROTALEX INC ownership
  • PROTALEX INC CEO
  • PROTALEX INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Zymergen Inc.
Update: Aug 26, 2022
XXSYS TECHNOLOGIES INC /CA
Update: Aug 25, 2022
WHISTLER INC
Update: Aug 25, 2022
WCG Clinical, Inc.
Update: Aug 25, 2022
Viventia Biotech Inc.
Update: Aug 24, 2022
VIACELL INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1674 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3598 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1368 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4024 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4502 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1226 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2225 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4925 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4563 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by